natgillin/translations-raw huggingface dataset:
As active Babesia infection might interfere with the development of protective immunity it is recommended to reduce exposure to ticks during the period of vaccination.
Ker lahko aktivna okužba z babezijo ovira razvoj zaščitne imunosti, je treba v času cepljenja poskrbeti za manjšo izpostavljenost klopom.
As active babesia infection might interfere with the development of protective immunity, it is recommended to reduce exposure to ticks during the period of vaccination.
Ker lahko aktivna okužba z babezijo ovira razvoj zaščitne imunosti, je treba v času cepljenja poskrbeti za manjšo izpostavljenost klopom.
As adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues associated with Porphyromonas spp. and Prevotella spp. (See also Section 12 ‘Special Warnings – For the animal’.)
Kot dodatno zdravljenje pri mehaničnih ali kirurških periodontalnih terapijah pri zdravljenju resnih infekcij dlesni in periodontalnega tkiva povezanih s Porphyromonas spp. in Prevotella spp. (Glejte tudi poglavje 12 » Posebna opozorila – za živali«)
As adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues associated with Porphyromonas spp. and Prevotella spp. (See also Section 4.5 ‘Special Precautions for Use’.)
Kot dodatno zdravljenje pri mehaničnih ali kirurških periodontalnih terapijah pri zdravljenju resnih infekcij dlesni in periodontalnega tkiva povezanih s Porphyromonas spp. in Prevotella spp.
As administration after food delays the time to maximal plasma concentration by approximately 2 hours no food should be eaten with or shortly before intake of Sonata.
Ker jemanje zdravila po hrani zadrži nastop maksimalne koncentracije v plazmi za približno 2 uri, ne uživajte hrane ob jemanju ali neposredno pred jemanjem zdravila Sonata
As administration after food delays the time to maximal plasma concentration by approximately 2 hours no food should be eaten with or shortly before intake of Zerene.
Ker jemanje zdravila po hrani zadrži nastop maksimalne koncentracije v plazmi za približno 2 uri, ne uživajte hrane ob jemanju ali neposredno pred jemanjem zdravila Zerene
As Aerivio Spiromax contains salmeterol and fluticasone propionate, the type and severity of adverse reactions associated with each of the active substance may be expected.
Zdravilo Airexar Spiromax vsebuje salmeterol in flutikazonpropionat, zato je mogoče pričakovati takšno vrsto in izrazitost neželenih učinkov, kot so povezane z vsako posamezno od teh dveh učinkovin.
As all five original studies were carried out with a technique known as ‘fundamental’ ultrasound imaging, the company also presented the results of some studies to show that the results seen using fundamental imaging could also be obtained when using the imaging techniques known as ‘harmonic’ and ‘non linear’.
Ker je bilo vseh pet prvotnih študij opravljenih s tehniko, znano kot „osnovni“ način ultrazvočnega slikanja, je družba predstavila tudi rezultate nekaterih študij, da bi dokazala, da je rezultate, vidne z osnovnim ultrazvočnim slikanjem, možno dobiti tudi z uporabo tehnik, znanih kot „harmonične“ in „nelinearne“ metode.
as an add-on to other antiepileptic medicines to treat:
kot dopolnilo drugim protiepileptičnim zdravilom za zdravljenje:
As an adjunct to diet and exercise for the treatment of obese patients (BMI  30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).
Kot dodatek k dieti in telesni dejavnosti za zdravljenje debelih bolnikov (ITM ≥ 30 kg/m2), ali bolnikov s čezmerno telesno maso (ITM > 27 kg/m2) z enim ali dvema spremljajočima dejavnikoma tveganja, kot sta diabetes tipa 2 ali dislipidemija (glejte poglavje 5.1).
As an adjunct to diet and exercise for the treatment of obese patients (BMI  30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).
Kot dodatek k dieti in telesni dejavnosti za zdravljenje debelih bolnikov (ITM ≥ 30 kg/m2), ali bolnikov s čezmerno telesno maso (ITM > 27 kg/m2) z enim ali dvema spremljajočima dejavnikoma tveganja, kot sta diabetes tipa 2 ali dislipidemija (glejte poglavje 5.1).
as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin.
kot dodatek k dieti in telesni vadbi za izboljšanje urejenosti glikemije pri odraslih bolnikih z neustrezno urejeno sladkorno boleznijo pri zdravljenju samo z metforminom v največjem odmerku, ki ga prenašajo, in pri bolnikih, ki se že zdravijo s kombinacijo alogliptina in metformina.
As an adjunct to medication, good management and hygiene practices should be introduced in order to reduce the risk of infection and to control the build-up of resistance.
Kot dodatek zdravljenju, bi morali uvesti dobro gospodarjenje in higienske prakse, da bi tako zmanjšali tveganje infekcije in za nadzor morebitne krepitve rezistence.
As an adjunct to medication, good management and hygiene practices should be introduced in order to reduce the risk of infection and to control the potential build-up of resistance.
Dodatno k zdravljenju je treba uvesti dobre prakse upravljanja in higiene, da se zmanjša tveganje za okužbo in da se nadzoruje morebitno naraščanje odpornosti na zdravilo.
As an adjunct to medication, good management and hygiene practices should be introduced in order to reduce the risk of infection and to control the potential build-up of resistance.
Kot dodatek zdravljenju uvedite dobro prakso upravljanja in dobro higiensko prakso, da boste zmanjšali nevarnost infekcije in obvladali morebitno krepitev rezistence.
As an adjunct to treatment, good management and hygiene practices should be introduced in order to reduce the risk of infection and to control the potential build-up of resistance.
Dodatno k zdravljenju je treba uvesti dobre prakse upravljanja in higiene, da se zmanjša tveganje za okužbo in da se nadzoruje morebitno naraščanje odpornosti na zdravilo.
As an aid in the management of overweight and obesity in adult dogs.
Kot dodatek pri nadziranju prekomerne telesne mase in debelosti pri odraslih psih
As an aid in the management of overweight and obesity in adult dogs.
Kot dodatek pri nadziranju prekomerne telesne mase in debelosti pri odraslih psih.
As an aid in the management of overweight and obesity in adult dogs.
Kot pripomoček pri obravnavi čezmerne teže in adipoznosti pri odraslih psih.
As an aid in the treatment of separation related disorders manifested by destruction and inappropriate elimination (defaecation and urination) and only in combination with behavioural modification techniques.
Podpora pri zdravljenju specifičnih vedenjskih motenj, ki se manifestirajo z destrukcijo in nenadzorovanim izločanjem (defekacija, uriniranje) samo v kombinaciji z določenimi tehnikami odprave vedenjskih motenj.
As an aid in the treatment of separation-related disorders in combination with behavioural modification techniques.
Kot podpora pri zdravljenju vedenjskih motenj v kombinaciji s prilagojenimi tehnikami vzgoje in vedenjske terapije
As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defaecation and/or urination) and only in combination with behavioural modification techniques.
Pripomoček pri zdravljenju motenj, povezanih z ločitvijo, ki se pri psih kaže v uničevanju in nesprejemljivem vedenju (lajanje in neustrezna defekacija oziroma uriniranje) ter samo v kombinaciji s tehnikami za spremembo vedenja.
As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate elimination (defaecation and urination) and only in combination with behavioural modification techniques.
Uporaba pri psih kot pomoč pri zdravljenju specifičnih vedenjskih motenj, ki se manifestirajo z destrukcijo in nenadzorovanim izločanjem (defekacija, uriniranje) skupaj s terapevtskimi tehnikami odprave vedenjskih motenj.
As an alternative to taking Telzir oral suspension:
Kot alternativa jemanju peroralne suspenzije Telzir
As an alternative, in case the oral solution is not available, the dose can be adjusted by increasing the dosage interval, also shown in the table.
Če peroralne raztopine ni na voljo, se odmerek alternativno lahko prilagodi tudi s podaljšanjem odmernega intervala, kar je tudi prikazano v tabeli.
As an example, a dose of 45 mg JEVTANA would require 4.5 ml of the concentrate solvent mixture prepared following Step 1.
Primer: odmerek 45 mg zdravila JEVTANA bi zahteval 4,5 ml mešanice koncentrata in vehikla, pripravljene v koraku 1.
As an example, for a 4-hour consumption of 22 l and a dosing pump rate of 1%, the volume of the stock solution should be 22 l x 0.01 = 220 ml.
Na primer, pri 4-urni porabi 22 l in hitrosti črpalke 1 % bo volumen osnovne raztopine 22 l x 0,01 = 220 ml.
As an exploratory analysis, female sexual partners completed two questionnaires at both the screening visit and week 36: the PDQ for Female Sexual Partners (an adaptation of Peyronie’s disease bother and psychological symptom domains of the PDQ for men, scoring from 0-12) and the Female Sexual Function Index (FSFI, scale from 2-36, where a higher score represents better sexual functioning).
Za eksploratorno analizo so ženske spolne partnerice izpolnile dva vprašalnika ob presejalnem obisku in obisku v 36. tednu: PDQ za ženske spolne partnerice (prilagojen vprašalnik domene težav in psiholoških simptomov zaradi Peyroniejeve bolezni (PDQ) za moške, z lestvico od 0–12) in indeksa ženske spolne funkcije (FSFI, Female Sexual Function Index, lestvica od 2–36, pri čemer je višji rezultat boljša spolna funkcija).
As an identified risk, an appropriate warning should be included in section 4.4. Moreover section 4.8 should be revised to reflect reactogenicity data from the three paediatric studies D-Pan H5N1-009, -013 and 032.
Glede na ugotovljeno tveganje je treba ustrezno opozorilo vključiti v poglavje 4.4. Poleg tega je treba poglavje 4.8 revidirati tako, da bo odražalo podatke o reaktogenosti, zbrane v treh pediatričnih študijah D-Pan H5N1-009, -013 in 032.
As an IgG1 monoclonal antibody, daclizumab is not expected to undergo renal elimination.
Kot monoklonsko protitelo IgG1 se ne pričakuje, da bi se daklizumab izločal skozi ledvice.
As an IgG1қ monoclonal antibody, renal excretion and hepatic enzyme-mediated metabolism of intact daratumumab are unlikely to represent major elimination routes.
Daratumumab je monoklonsko protitelo IgG1қ,zato je malo verjetno, da bi izločanje skozi ledvice in presnova nespremenjenega daratumumaba z jetrnimi encimi predstavljala poglavitna načina izločanja iz telesa.
as an infusion or as a tablet to prevent ‘skeletal events’ (fractures [broken bones] or bone complications requiring treatment) in patients with breast cancer and bone metastases (when the cancer has spread to the bone); as an infusion to treat hypercalcaemia (high levels of calcium in the blood) caused by tumours.
kot infuzija ali tableta za preprečevanje z okostjem povezanih dogodkov (fraktur [zlomljenih kosti] ali zapletov s kostmi, pri katerih je potrebno zdravljenje) pri bolnikih z rakom dojke in metastazami v kosteh (kadar se rak razširi na kosti); kot infuzija za zdravljenje hiperkalciemije (visokih ravni kalcija v krvi), ki jo povzročajo tumorji.
as an infusion or as a tablet to prevent ‘skeletal events’ (fractures [broken bones] or bone complications requiring treatment) in patients with breast cancer and bone metastases (when the cancer has spread to the bone); as an infusion to treat hypercalcaemia (high levels of calcium in the blood) caused by tumours.
kot infuzija ali tableta za preprečevanje z okostjem povezanih dogodkov (zlomov kosti ali zapletov s kostmi, pri katerih je potrebno zdravljenje) pri bolnikih z rakom dojke in metastazami v kosteh (kadar se rak razširi na kosti); kot infuzija za zdravljenje hiperkalciemije (visokih ravni kalcija v krvi), ki jo povzročajo tumorji.
As anaesthetic drugs may affect renal perfusion, the use of parenteral fluid therapy during surgery should be considered to decrease potential renal complications when using NSAIDs peri-operatively.
Ker lahko anestetiki vplivajo na perfuzijo ledvic, je med operativnimi posegi priporočljivo parenteralno nadomeščanje tekočin, da se ob perioperativni uporabi NSAID zmanjša možnost nastanka ledvičnih zapletov.
As anaesthetics may affect renal perfusion, the use of parenteral fluid therapy during surgery should be considered to decrease potential renal complications when using NSAIDs peri-operatively.
Ker lahko anestetiki vplivajo na ledvični pretok, je treba pri perioperativni uporabi NSAID premisliti o uporabi parenteralne tekočinske terapije med operativnim posegom za zmanjšanje potencialnih ledvičnih komplikacij.
As animal reproduction studies are not always predictive of human response, Herceptin should be avoided during pregnancy unless the potential benefit for the mother outweighs the potential risk to the foetus.
Izsledki študij o vplivu na sposobnost za razmnoževanje pri živalih ne veljajo vedno tudi za ljudi, zato se moramo uporabi zdravila Herceptin med nosečnostjo izogibati, razen v primerih, ko pričakovana korist za mater upravičuje tveganje za plod.
As animal studies have shown excretion of small amounts of aclidinium bromide and/or metabolites into milk, a decision must be made whether to discontinue breast-feeding or to discontinue therapy with aclidinium bromide taking into account the benefit of breast-feeding for the child and the benefit of long-term aclidinium bromide therapy to the woman.
Študije na živalih so pokazale izločanje majhne količine aklidinijevega bromida in/ali presnovkov v materino mleko, zato se je treba odločiti med prenehanjem dojenja ali prenehanjem zdravljenja z aklidinijevim bromidom, pri čemer je treba pretehtati prednosti dojenja za otroka in prednosti dolgotrajnega zdravljenja z aklidinijevim bromidom za mater.
As anticholinergic bronchodilator medicines may have an effect on the heart and blood vessels, the company will closely monitor the medicine’s cardiovascular effects and will carry out a further study in patients to identify any potential risks.
Antiholinergična bronhodilatacijska zdravila lahko vplivajo na srce in ožilje, zato bo družba pozorno spremljala učinke zdravila na srce in ožilje ter izvedla dodatno študijo pri bolnikih za ugotovitev morebitnih tveganj.
As anticholinergic bronchodilator medicines may have an effect on the heart and blood vessels, the company will continue to closely monitor the medicine’s cardiovascular effects and will carry out a further study in patients to identify any potential risks.
Antiholinergična bronhodilatacijska zdravila lahko vplivajo na srce in ožilje, zato bo družba pozorno spremljala učinke zdravila na srce in ožilje ter izvedla dodatno študijo pri bolnikih za ugotovitev morebitnih tveganj.
As anticholinergics are mainly eliminated by biotransformation, the potential for an interaction is limited, although an interaction with anticholinergics has not been investigated.
Čeprav interakcij z antiholinergiki niso raziskovali, je možnost, da bi do njih prišlo, majhna, saj se antiholinergiki izločajo v glavnem z biotransformacijo.
As anticipated due to the concomitant immunosuppression, the rate of emergence of YMDD mutant HBV after 52 weeks treatment was higher (36 %-64 %) in the liver transplant population than in the immunocompetent CHB patients (14 %-32 %).
Kot je bilo pričakovano zaradi spremljajoče imunosupresije, je bil odstotek pojavnosti variante YMDD mutanta HBV po 52 tednih zdravljenja večji (36 do 64 %) pri bolnikih s presaditvijo jeter kot pri imunokompetentnih bolnikih s kroničnim hepatitisom B (14 do 32 %).
As antimuscarinic bronchodilator medicines may have an effect on the heart and blood vessels, the company will continue to closely monitor the medicine’s cardiovascular effects and will carry out a further study in patients to identify any potential risks.
Antimuskarinska bronhodilatacijska zdravila lahko vplivajo na srce in ožilje, zato bo družba pozorno spremljala učinke zdravila na srce in ožilje ter izvedla dodatno študijo pri bolnikih za ugotovitev morebitnih tveganj.
As Atripla contains efavirenz, emtricitabine and tenofovir disoproxil fumarate, any interactions that have been identified with these agents individually may occur with Atripla.
Zdravilo Atripla vsebuje efavirenz, emtricitabin in dizoproksiltenofovirijev fumarat, zato se pri njegovi uporabi lahko pojavijo katerekoli interakcije, ki so jih opazili pri uporabi teh posameznih učinkovin.
As AUBAGIO decreases the number of white cells in the blood this may affect your ability to fight the infection.
Ker zdravilo AUBAGIO zmanjšuje število belih krvničk v krvi, lahko to vpliva na vašo sposobnost boja proti okužbam.
As bacterial overgrowth in the gut is associated with the development of necrotising enterocolitis, co- administration of caffeine citrate with medicinal products that suppress gastric acid secretion (antihistamine H2 receptor blockers or proton-pump inhibitors) may in theory increase the risk of necrotising enterocolitis (see section 4.4 and 4.8).
Ker je razbohotenje bakterij v črevesju povezano z razvojem nekrotizirajočega enterokolitisa, lahko sočasna uporaba kofeinijevega citrata z zdravili, ki zavirajo izločanje želodčne kisline (zaviralci histaminskih receptorjev H2 ali zaviralci protonske črpalke), teoretično zvečajo tveganje nekrotizirajočega enterokolitisa (glejte poglavji 4.4 in 4.8).
As Bemfola pre-filled pen with single-dose cartridge is intended for only one injection, clear instructions should be provided to the patients to avoid misuse of the single dose presentation.
Ker je zdravilo Bemfola napolnjen injekcijski peresnik z enoodmernim vložkom namenjeno samo enkratnemu injiciranju, mora dobiti bolnik jasna navodila za uporabo, v izogib napačni uporabi enoodmerne oblike zdravila.
As Beromun is always administered by experienced and qualified hospital doctors, accidental overdose is extremely unlikely.
Ker uporabljajo zdravilo Beromun le izkušeni zdravniki, usposobljeni za njegovo uporabo, je nenameren vnos prevelikega odmerka zelo malo verjeten.
As both passive and active processes are involved, there is the potential for competition for elimination with other renally eliminated active substances.
Ker so vpleteni pasivni in aktivni procesi, obstaja možnost za kompeticijo pri izločanju z drugimi učinkovinami, ki se izločajo skozi ledvice.
As can happen in patients having this type of medicine (immune-suppressants), a very small number of CellCept patients have developed cancer of the lymphoid tissues and skin.
Kot se lahko zgodi pri bolnikih, ki jemljejo takšno vrsto zdravil (zdravila za zaviranje imunske odzivnosti), se je pri zelo majhnem številu bolnikov, ki so jemali zdravilo CellCept, pojavil rak limfatičnih tkiv in kože.
As cases of tuberculosis have been reported in patients treated with Humira, your doctor will check you for signs and symptoms of tuberculosis before starting Humira.
Ker so bili pri bolnikih, zdravljenih z zdravilom Humira, opisani primeri tuberkuloze, vas bo zdravnik pred začetkom zdravljenja z zdravilom Humira preiskal glede znakov in simptomov tuberkuloze.
As cases of tuberculosis have been reported in patients treated with Humira, your doctor will check your child for signs and symptoms of tuberculosis before starting Humira.
Ker so bili pri bolnikih, zdravljenih z zdravilom Humira, opisani primeri tuberkuloze, bo zdravnik vašega otroka pred začetkom zdravljenja z zdravilom Humira preiskal glede znakov in simptomov tuberkuloze.
As cases of tuberculosis have been reported in patients treated with Trudexa, your doctor will check you for signs and symptoms of tuberculosis before starting Trudexa.
Ker so bili pri bolnikih, zdravljenih s Trudexo, opisani primeri tuberkuloze, vas bo zdravnik pred začetkom zdravljenja s Trudexo preiskal glede znakov in simptomov tuberkuloze.
As cerebral oedema has also been reported in patients with hypermethioninemia, secondary hypermethioninemia due to betaine anhydrous therapy has been postulated as a possible mechanism of action.
3.000 µM. Ker so pri bolnikih s hipermetioninemijo poročali tudi o možganskem edemu, so domnevali, da je možni mehanizem delovanja sekundarna hipermetioninemija zaradi zdravljenja z brezvodnim betainom.
As clearance is reduced, patients with mild to moderate hepatic impairment should be treated with Sonata 5 mg.
Ker je očistek zdravila zmanjšan, morate bolnike z blago do zmerno jetrno okvaro zdraviti z zdravilom Sonata 5 mg.
As clearance is reduced, patients with mild to moderate hepatic impairment should be treated with Zerene 5 mg.
Ker je očistek zdravila zmanjšan, morate bolnike z blago do zmerno jetrno okvaro zdraviti z zdravilom Zerene 5 mg.
As clinical data are limited in patients with mild to moderate hepatic impairment and pharmacokinetic and clinical data are missing in patients with severe hepatic impairment, eslicarbazepine acetate should be used with caution in patients with mild to moderate hepatic impairment and is not recommended in patients with severe hepatic impairment.
Pri bolnikih z blago do zmerno jetrno okvaro so klinični podatki omejeni, pri bolnikih s hudo jetrno okvaro pa farmakokinetičnih in kliničnih podatkov ni, zato je treba pri bolnikih z blago do zmerno jetrno okvaro eslikarbazepinacetat uporabljati previdno, pri bolnikih s hudo jetrno okvaro pa njegova uporaba ni priporočena.
as co-administration may
premljanje uporabe teh
as combination therapy
kombinirano zdravljenje
as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
kot kombinirano zdravljenje z insulinom (z ali brez metformina), kadar ta režim zdravljenja sam, z dieto in telesno dejavnostjo, ne zagotovi ustrezne urejenosti glikemije.
As compared to the BID regimen, the once daily dosing is associated with a reduction in the Cmin/Ctrough values of approximately 50%.
V primerjavi s shemo dvakrat na dan je bilo odmerjanje enkrat na dan povezano z zmanjšanjem vrednosti Cmin/Ctrough za približno 50%.
As compared to the BID regimen, the once-daily dosing is associated with a reduction in the Cmin/Ctrough values of approximately 50%.
V primerjavi s shemo dvakrat na dan je bilo odmerjanje enkrat na dan povezano z zmanjšanjem vrednosti Cmin/Ctrough za približno 50%.
As compared to the combination of boceprevir with peginterferon alfa–2b and ribavirin, the combination of boceprevir with peginterferon alfa–2a and ribavirin was associated with a higher rate of neutropenia (including grade 4 neutropenia) and a higher rate of infections.
V primerjavi s kombinacijo boceprevirja in peginterferona alfa-2b ter ribavirina je bila kombinacija boceprevirja s peginterferonom alfa-2a in ribavirinom povezana z večjim deležem nevtropenije (vključno z nevtropenijo stopnje 4) in večjim deležem okužb.
As Competact contains metformin hydrochloride, the treatment should be discontinued 48 hours before elective surgery with general anaesthesia and should not be usually resumed earlier than 48 hours afterwards.
Ker zdravilo Competact vsebuje metforminijev klorid, je potrebno zdravljenje prekiniti 48 ur pred načrtovanim operativnim posegom v splošni anesteziji, z njim pa običajno ne smemo nadaljevati prej kot v 48 urah po posegu.
As concentrations fall below this level, expression of the CD25 antigen returns to pretherapy values within 1–2 weeks.
Ko se koncentracije zmanjšajo pod to vrednost, se izraženost antigena CD25 v 1 do 2 tednih vrne na vrednosti pred zdravljenjem.
As crizotinib is extensively metabolized in the liver, hepatic impairment is likely to increase plasma crizotinib concentrations.
Ker se krizotinib obsežno presnavlja v jetrih, je verjetno, da okvara jeter zveča koncentracije krizotiniba v plazmi.